ALUR OTC
Allurion Technologies Inc.
1W: -60.9%
1M: -62.9%
3M: -38.9%
YTD: -70.1%
1Y: -80.2%
3Y: -99.4%
5Y: -99.8%
$0.43
-0.34 (-44.14%)
Weekly Expected Move ±28.3%
$0
$0
$0
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
22 relationships22
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2023-08-07
Earliest Filing
2025-02-21
Latest Filing
investor: 14
partner: 6
acquirer: 1
target: 1
Counterparties (Filed by ALUR)
22 relationshipsCompanies named in ALUR's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Leavitt Equity Partners | — | investor | Accredited investor participating in the private placement | 2025-02-21 | View |
| Roth Capital Partners, LLC | — | partner | Placement agent for the private placement of common stock and warrants. | 2025-01-28 | View |
| RTW Investments, LP | — | investor | Allurion Technologies, Inc. sold 841,751 shares of common stock to funds affiliated with RTW Investments, LP for approxi | 2025-01-17 | View |
| RTW Investments, LP | — | investor | Principal purchaser of convertible notes and investment manager for RIFA investors | 2025-01-08 | View |
| Allurion Australia Pty Ltd | — | partner | Signatory to Omnibus Amendment regarding marketing authorization in Australia | 2025-01-08 | View |
| Allurion France | — | partner | Signatory to Omnibus Amendment regarding marketing authorization in France | 2025-01-08 | View |
| RTW Master Fund, Ltd. | — | investor | Signatory to Omnibus Amendment | 2025-01-08 | View |
| RTW Innovation Master Fund, Ltd. | — | investor | Signatory to Omnibus Amendment | 2025-01-08 | View |
| RTW Biotech Opportunities Operating Ltd. | — | investor | Signatory to Omnibus Amendment | 2025-01-08 | View |
| RTW Master Fund, Ltd. | — | investor | Investor providing revenue interest financing to Allurion Technologies, LLC | 2024-11-04 | View |
| RTW Innovation Master Fund, Ltd. | — | investor | Investor providing revenue interest financing to Allurion Technologies, LLC | 2024-11-04 | View |
| RTW Biotech Opportunities Operating Ltd. | — | investor | Investor providing revenue interest financing to Allurion Technologies, LLC | 2024-11-04 | View |
| RTW Investments, LP | — | investor | Significant stockholder and investor in the private placement | 2024-07-01 | View |
| Chardan Capital Markets LLC | — | investor | Entered into a ChEF Purchase Agreement and Registration Rights Agreement to provide a committed equity facility for the | 2023-12-19 | View |
| Compute Health Acquisition Corp. | CPUH | acquirer | Sponsor of the business combination with Allurion Technologies. | 2023-08-07 | View |
| Compute Health Corp. | — | partner | Wholly-owned subsidiary of Compute Health Acquisition Corp. used in the merger. | 2023-08-07 | View |
| Compute Health LLC | — | partner | Wholly-owned subsidiary of Compute Health Acquisition Corp. used in the merger. | 2023-08-07 | View |
| Allurion Technologies Opco, Inc. | ALUR | target | Operating company merged into the new entity. | 2023-08-07 | View |
| RTW Investments, LP | — | investor | Investment manager for RTW entities entering into revenue interest financing. | 2023-08-07 | View |
| Medtronic, plc | MDT | investor | Shareholder that entered into a non-redemption agreement. | 2023-08-07 | View |
| Hunter Ventures Limited | — | investor | Investor holding convertible notes and entering into backstop agreement. | 2023-08-07 | View |
| Chardan Capital Markets LLC | — | partner | Counterparty to the ChEF Purchase Agreement for equity funding. | 2023-08-07 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-03-12 | Notice of Delisting or Transfer; Other Events; Financial Statements and Exhibits | View | |
| 2026-02-25 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Material Modifica | Agreement | View |
| 2026-02-23 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-01-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-12-19 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2025-11-12 | Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Unregistere | Agreement | View |
| 2025-10-03 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-08-13 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-08-07 | Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities; Re | View | |
| 2025-05-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-17 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2025-04-10 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2025-04-03 | Other Events; Financial Statements and Exhibits | View | |
| 2025-03-26 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-21 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin | Agreement | View |
| 2025-02-13 | Other Events; Financial Statements and Exhibits | View | |
| 2025-01-28 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin | Agreement | View |
| 2025-01-17 | Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Unregistere | Agreement | View |
| 2025-01-08 | Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Regulation | Agreement | View |
| 2025-01-06 | Departure/Election of Directors; Appointment of Officers | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR